Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Sigma-Aldrich signs agreement with PHE to manufacture, supply bacterial and fungal NCTC/NCPF CRMs

Sigma-Aldrich Corporation, a leading Life Science and Technology Company, today announced it has signed an agreement with Public Health England to manufacture and supply bacterial and fungal NCTC/NCPF Certified Reference Materials (CRM) in LENTICULE disc format worldwide for use as controls in food, water, environmental and clinical testing microbiology laboratories.

27 Aug 2015

University of Nottingham to lead £6.5m research project that aims to develop next generation biomaterials

The University of Nottingham is to lead a £6.5m research project which aims to make the leap from 2D to 3D in the development of advanced materials and realise the true potential of regenerative medicine and medical devices for the future.

27 Aug 2015

Sandia researchers develop nerve-like polymer network using biological mechanisms

Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.

25 Aug 2015

Shire enters into agreement with Sanquin for CINRYZE

Shire plc announced today it has entered into an agreement with Sanquin Blood Supply, the manufacturer of CINRYZE (C1 esterase inhibitor [human]), providing Shire access to its manufacturing technology and allowing Shire to source additional manufacturers to meet the growing demand for CINRYZE.

25 Aug 2015

Improved ‘two-shot’ mould clear bottomed assay plates

The unique Krystal 2000 microplate range from Porvair Sciences has been optimised for luminescence and fluorescence assays.

24 Aug 2015

NYBC, UC Davis Health System partner to manufacture potential stem cell therapies

New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.

20 Aug 2015

Study shows how single-cell organisms can somersault or bend their bodies

In a paper appearing in Scientific Reports today, the motion of micro-organisms as they swim through various types of fluid channels show "quite strange and new" responses for single cell organisms, including the performance of somersaults, meandering wanderings, and even a ballistic type of behavior, wrote Sunghwan "Sunny" Jung, a member of the Virginia Tech Department of Biomedical Engineering and Mechanics.

20 Aug 2015

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira today announced that Inflectra (infliximab), the first monoclonal antibody (mAb) biosimilar therapy, has been registered in Australia. This registration paves the way for the Federal Government to reduce the cost of some of the most expensive medicines on the Pharmaceutical Benefits Scheme (PBS).

20 Aug 2015

NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the National Institute of Allergy and Infectious Diseases has exercised its option to advance the development of Soligenix's heat stabilized ricin toxin vaccine, RiVax.

19 Aug 2015

IDT webinar explores effective RNAi and antisense oligo methods

Integrated DNA Technologies (IDT) will host an informative webinar, entitled ‘Knockdown of lncRNAs: exploring RNAi and antisense oligo methods’, on Tuesday, August 25, 2015. Kim Lennox, a research scientist at IDT and expert in the suppression of gene expression, will present the webinar at 9 am and 1 pm Central Standard Time.

From Integrated DNA Technologies 19 Aug 2015

Synthorx employs synthetic DNA technology to produce proteins containing novel amino acids

Synthorx Inc. announced today that the company has employed its proprietary protein expression system to successfully produce proteins containing novel amino acids. Using a semi-synthetic DNA template (containing the synthetic base pair X and Y), Synthorx scientists were able to produce RNA containing X and Y, which was used with an otherwise fully natural biological system, to efficiently direct the incorporation of multiple novel amino acids at different sites in proteins.

19 Aug 2015

Hi-Tech acquires LG Sciences brand of Sports Nutrition and Bodybuilding products

Hi-Tech Pharmaceuticals, a leading global provider of Sports Nutrition, Weight loss products, and Contract Manufacturing services, and LG Sciences, one of the premier Sports Nutrition and Bodybuilding brands in the United States, today announced that Hi-Tech has acquired LG Sciences brand of Sports Nutrition products and Bodybuilding products.

18 Aug 2015

EPGL challenges Google in smart contact lens revolution

EP Global Communications, Inc. announces a challenge to Google to confirm it is up to speed with EPGL in the smart contact lens revolution.

18 Aug 2015

Opioids produced by yeast; revealing the potential for cheaper pain relief

Researchers at Stanford University have genetically engineered yeast so it produces hydrocodone, a semi-synthetic opioid analgesic used in the United States for relief of moderate to severe pain.

14 Aug 2015

CPhI reports positive outlook on the Chinese pharmaceutical market

CPhI – a division of UBM EMEA – alongside UBM Sinexpo, announces the findings of the Pharma Insights China 2015 report.

13 Aug 2015

Dipexium reports net loss of $4.0 million for second quarter 2015

Dipexium Pharmaceuticals, Inc., a late-stage pharmaceutical company focused on the development and commercialization of Locilex (pexiganan cream 0.8%), a novel, broad-spectrum, topical antibiotic peptide, today reported financial results for the quarter ended June 30, 2015.

13 Aug 2015

VTT develops miniature gas sensor for mobile devices to detect internal air problems

VTT Technical Research Centre of Finland has developed a miniature gas sensor that can be connected to mobile devices. Gas measurements made with smartphones will make activities such as the detection of internal air problems easier. In addition, sleep quality will be measurable with greater precision, using mobile healthcare applications which gauge carbon dioxide quantities.

13 Aug 2015

Echo's non-invasive CGM system to be designated as Class 2 medical device in China

Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.

12 Aug 2015

CMC Biologics, PATH Malaria Vaccine Initiative sign agreement for development of specific monoclonal antibodies

CMC Biologics, a global leader in clinical and commercial development and contract manufacture of therapeutic proteins, announced today it has entered into an agreement with the PATH Malaria Vaccine Initiative (MVI) for process development and manufacture of specific monoclonal antibodies to test for their capacity to protect humans from malaria infection.

12 Aug 2015

Janssen signs license agreement with Alligator Bioscience for immuno-oncology antibody

Janssen Biotech, Inc., one of the Janssen pharmaceutical companies of Johnson & Johnson announced today an exclusive, worldwide license agreement with Alligator Bioscience AB for ADC-1013, an immuno-oncology agent currently in Phase 1 clinical studies.

12 Aug 2015

Manufacturing News and Research

Further Reading

Sigma-Aldrich signs agreement with PHE to manufacture, supply bacterial and fungal NCTC/NCPF CRMs

University of Nottingham to lead £6.5m research project that aims to develop next generation biomaterials

Sandia researchers develop nerve-like polymer network using biological mechanisms

Shire enters into agreement with Sanquin for CINRYZE

Improved ‘two-shot’ mould clear bottomed assay plates

NYBC, UC Davis Health System partner to manufacture potential stem cell therapies

Study shows how single-cell organisms can somersault or bend their bodies

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

NIAID exercises option to advance development of Soligenix's heat stabilized ricin toxin vaccine

IDT webinar explores effective RNAi and antisense oligo methods

Synthorx employs synthetic DNA technology to produce proteins containing novel amino acids

Hi-Tech acquires LG Sciences brand of Sports Nutrition and Bodybuilding products

EPGL challenges Google in smart contact lens revolution

Opioids produced by yeast; revealing the potential for cheaper pain relief

CPhI reports positive outlook on the Chinese pharmaceutical market

Dipexium reports net loss of $4.0 million for second quarter 2015

VTT develops miniature gas sensor for mobile devices to detect internal air problems

Echo's non-invasive CGM system to be designated as Class 2 medical device in China

CMC Biologics, PATH Malaria Vaccine Initiative sign agreement for development of specific monoclonal antibodies

Janssen signs license agreement with Alligator Bioscience for immuno-oncology antibody

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News